1. Hemodynamic assessment of amrinone: a new inotropic agent;Benotti, JR, Grossman; W, Braunwald; E, Davolos; DD, Alousi; A.A.;N EnglJa Med,1978
2. Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure;LeJemtel, T.H.; Keung, E.; Ribner, H.S.;Am J Cardiol,1980
3. The haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function;Wilmshurst, P.T.; Thompson, D.S.; Jenkins, B.S.; Coltart, D.J.; Webb-Peploe, M.M.;Br Heart J,1983
4. Amrinone;Alousi, A.A.; Edelson, J.,1981
5. High performance liquid chromatographic analysis of amrinone and its N-acetyl derivative in plasma. Pharmacokinetics of amrinone in the dog;Kullberg, M.P.; Dorrbecker, B.; Lennon, J.; Rowe, E.; Edelson, J.;J Chromatogr,1980